Ipca Laboratories (NSE:IPCALAB) Other Current Liabilities : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Ipca Laboratories Other Current Liabilities?

Ipca Laboratories's other current liabilities for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ipca Laboratories's quarterly other current liabilities increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹5,838 Mil) but then declined from Sep. 2023 (₹5,838 Mil) to Dec. 2023 (₹0 Mil).

Ipca Laboratories's annual other current liabilities increased from Mar. 2021 (₹1,363 Mil) to Mar. 2022 (₹3,238 Mil) and increased from Mar. 2022 (₹3,238 Mil) to Mar. 2023 (₹3,413 Mil).

Ipca Laboratories Other Current Liabilities Historical Data

The historical data trend for Ipca Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Other Current Liabilities Chart

Ipca Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Current Liabilities

Get a 7-Day Free Trial

Ipca Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Ipca Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Ipca Laboratories Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (NSE:IPCALAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » Other Current Liabilities

Traded in Other Exchanges

524494:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines